Ultragenyx Pharmaceutical Inc. (RARE) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.83 | +7.3% |
| 2024 | $-6.29 | +23.8% |
| 2023 | $-8.25 | +18.5% |
| 2022 | $-10.12 | -51.0% |
| 2021 | $-6.70 | -118.2% |
| 2020 | $-3.07 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.83 | +7.3% |
| 2024 | $-6.29 | +23.8% |
| 2023 | $-8.25 | +18.5% |
| 2022 | $-10.12 | -51.0% |
| 2021 | $-6.70 | -118.2% |
| 2020 | $-3.07 | — |